Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation
Osteoprotective Medication in the Era of Novel Agents
Proteasome Inhibition: the Dawn of Novel Therapies in Multiple Myeloma
Risk of Disease Recurrence and Survival in Patients with Multiple Myeloma: A German Study Group Analysis Using a Conditional Survival Approach with Long-term Follow-up of 815 Patients
Long-term Complete Remission of Refractory Severe Idiopathic Immune Thrombocytopenia (ITP) Treated with Daratumumab
Validation of the Revised Myeloma Comorbidity Index and Other Comorbidity Scores in a Multicenter German Study Group Multiple Myeloma Trial
Palbociclib in Acute Leukemias with KMT2A-rearrangement: Results of AMLSG 23-14 Trial
A Prospective Single-center Study on CNI-free GVHD Prophylaxis with Everolimus Plus Mycophenolate Mofetil in Allogeneic HCT
Correction To: Prognostic Factors for Survival After Allogeneic Transplantation in Acute Lymphoblastic Leukemia
Phase II Trial of Hypomethylating Agent Combined with Nivolumab for Acute Myeloid Leukaemia Relapse After Allogeneic Haematopoietic Cell Transplantation - Immune Signature Correlates with Response
Plasma Cell Leukemia: Another Piece of the Puzzle
Prognostic Factors for Survival After Allogeneic Transplantation in Acute Lymphoblastic Leukemia
Dapsone-induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses
General Condition and Comorbidity of Long-term Survivors of Adult Acute Lymphoblastic Leukemia
Cardiovascular Adverse Events in Modern Myeloma Therapy - Incidence and Risks. A Review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
Activity of Decitabine Combined with All-trans Retinoic Acid in Oligoblastic AML: Results from a Randomized 2x2 Phase II Trial (DECIDER)
Case Report: Refusal of an Veno-arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid Leukemia
Allogeneic Transplantation of Multiple Myeloma Patients May Allow Long-term Survival in Carefully Selected Patients with Acceptable Toxicity and Preserved Quality of Life
Clinical Characteristics and Outcome of Multiple Myeloma Patients with Concomitant COVID-19 at Comprehensive Cancer Centers in Germany
From Transplant to Novel Cellular Therapies in Multiple Myeloma